A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Increased stathmin in serum as a potential tumor marker for lung adenocarcinoma
2017
Japanese Journal of Clinical Oncology
Stathmin has been found to be involved in malignant tumors; the aim of this study was to investigate the relationship between serum stathmin and clinico-pathological features of lung cancer. Methods: In three lung cancer cell lines, stathmin expression and its secretion level in the supernatant were examined by Western blot and enzyme-linked immunosorbent assay (ELISA). Expression of stathmin was examined by immunohistochemistry in 48 lung cancer tissues, and serum stathmin expression level was
doi:10.1093/jjco/hyx005
pmid:28158640
fatcat:o3md2fanerfdhgr5bnox56ww4e